THURSDAY, June 26, 2025 (HealthDay News) -- Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial ...
The risk for acute kidney injury was not higher among patients with an eGFR dip at empagliflozin initiation. Previous studies have reported renal benefits with sodium glucose cotransporter 2 inhibitor ...
Intranasal insulin increased mPACC-5, modulated fractional anisotropy and cerebral blood flow. HealthDay News — Intranasal insulin (INI) and empagliflozin are safe and have promising effects on ...
Compared with baseline, by 24 months, the estimated glomerular filtration rate was similar in the empagliflozin group, but decreased in the placebo group. HealthDay News — Empagliflozin has kidney ...
MONDAY, Oct. 27, 2025 (HealthDay News) -- Intranasal insulin (INI) and empagliflozin are safe and have promising effects on cognition, according to a study published online Oct. 7 in Alzheimer's & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback